🇺🇸 FDA
Pipeline program

NPC-11 for intravenous or oral administration.

NPC-11-1

Phase 3 small_molecule completed

Quick answer

NPC-11 for intravenous or oral administration. for Apnea of Prematurity is a Phase 3 program (small_molecule) at Belpharma s.a. with 1 ClinicalTrials.gov record(s).

Program details

Company
Belpharma s.a.
Indication
Apnea of Prematurity
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials